Family Office Research LLC Buys New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Family Office Research LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 437 shares of the healthcare conglomerate's stock, valued at approximately $221,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth about $341,000. Principal Financial Group Inc. grew its stake in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after purchasing an additional 180,479 shares in the last quarter. Sunbelt Securities Inc. boosted its holdings in shares of UnitedHealth Group by 0.9% in the 3rd quarter. Sunbelt Securities Inc. now owns 2,790 shares of the healthcare conglomerate's stock valued at $1,631,000 after buying an additional 24 shares during the last quarter. M&T Bank Corp raised its position in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after acquiring an additional 26,074 shares in the last quarter. Finally, McIlrath & Eck LLC grew its position in shares of UnitedHealth Group by 8.2% in the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock valued at $371,000 after acquiring an additional 48 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Truist Financial lifted their price target on UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday. KeyCorp restated an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Twenty-one investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and a consensus target price of $632.85.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $2.05 during midday trading on Tuesday, reaching $585.01. The company's stock had a trading volume of 1,839,388 shares, compared to its average volume of 4,336,990. The business has a 50-day moving average price of $513.80 and a 200-day moving average price of $541.83. UnitedHealth Group Incorporated has a 52 week low of $438.50 and a 52 week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $535.12 billion, a PE ratio of 37.74, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company's revenue was up 6.8% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.44%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.